Presentation is loading. Please wait.

Presentation is loading. Please wait.

Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome  Daniel G. Luba, James A. DiSario, Colleen.

Similar presentations


Presentation on theme: "Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome  Daniel G. Luba, James A. DiSario, Colleen."— Presentation transcript:

1 Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome  Daniel G. Luba, James A. DiSario, Colleen Rock, Devki Saraiya, Kelsey Moyes, Krystal Brown, Kristen Rushton, Maydeen M. Ogara, Mona Raphael, Dayna Zimmerman, Kimmie Garrido, Evelyn Silguero, Jonathan Nelson, Matthew B. Yurgelun, Fay Kastrinos, Richard J. Wenstrup, Sapna Syngal  Clinical Gastroenterology and Hepatology  Volume 16, Issue 1, Pages (January 2018) DOI: /j.cgh Copyright © 2018 AGA Institute Terms and Conditions

2 Figure 1 Personal/family history data collected by the patient self-administered PREMM1,2,6. Clinical Gastroenterology and Hepatology  , 49-58DOI: ( /j.cgh ) Copyright © 2018 AGA Institute Terms and Conditions

3 Figure 2 Sample output of the patient self-administered PREMM1,2,6. NCCN, National Comprehensive Cancer Network. Clinical Gastroenterology and Hepatology  , 49-58DOI: ( /j.cgh ) Copyright © 2018 AGA Institute Terms and Conditions


Download ppt "Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome  Daniel G. Luba, James A. DiSario, Colleen."

Similar presentations


Ads by Google